AI assistant
Sending…
CEMTREX INC — Director's Dealing 2017
Mar 6, 2017
34786_dirs_2017-03-06_77deee52-8baf-4c9b-9a8a-2153c9c03f43.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CEMTREX INC (CETX)
CIK: 0001435064
Period of Report: 2013-02-28
Reporting Person: GOVIL SAAGAR (Chairman, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-28 | Common Stock | P | 1667 | $0.77 | Acquired | 1339555 | Direct |
| 2014-06-25 | Common Stock | P | 350 | $5.96 | Acquired | 1339905 | Direct |
| 2015-04-07 | Common Stock | P | 17 | $2.85 | Acquired | 1339922 | Direct |
| 2015-05-12 | Common Stock | P | 50 | $3.90 | Acquired | 1339972 | Direct |
| 2017-02-27 | Common Stock | P | 1000 | $3.80 | Acquired | 1340972 | Direct |
| 2017-02-28 | Common Stock | P | 1000 | $3.71 | Acquired | 1341.972 | Direct |
| 2017-02-28 | Common Stock | P | 3000 | $3.72 | Acquired | 1344972 | Direct |
| 2017-02-28 | Common Stock | P | 1000 | $3.70 | Acquired | 1345972 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-12 | Common Stock Options | $1.70 | A | 200000 | Acquired | 2022-02-12 | Common Stock (200000) | Direct |
| 2016-12-05 | Common Stock Options | $4.24 | A | 200000 | Acquired | 2022-12-05 | Common Stock (200000) | Direct |
Footnotes
F1: Options vest 50% one year from date of grant and remaining 50% two years from date of grant.
F2: On April 15, 2015 a 6 for 1 reverse stock split was made effective for Cemtrex, Inc. common stock. All share amounts and per share pricing have been adjusted to reflect this reverse stock split.
More from CEMTREX INC
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 11
Annual Report
2026
Jan 16
Prospectus
2026
Jan 9
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 8
Prospectus
2025
Dec 30